Condition
Substance-Related Disorder
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
Early P 1 (1)
Trial Status
Completed3
Withdrawn1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06858527Not ApplicableRecruiting
Deficit Hyperactivity Disorder / Substance Use Disorder Comorbidity in Integrated Treatment
NCT04533542CompletedPrimary
Nicotine Vapor Specific Sensory Measurement
NCT02954679Completed
French Study on COgnitive Enhancement and Consumption of Psychoactive Substances Among Youth Students
NCT00865956Not ApplicableWithdrawnPrimary
A Comprehensive Disease Management Program for Medically-Complex Substance Users
NCT01951508Early Phase 1Completed
Effects of Methylphenidate, Modafinil, and MDMA on Emotion-processing in Humans: A Pharmaco-fMRI Study
Showing all 5 trials